Search alternatives:
hong » long (Expand Search), kong (Expand Search)
hongyu » longyu (Expand Search), kongyu (Expand Search)
honey » money (Expand Search)
bdone » done (Expand Search), bone (Expand Search), bhone (Expand Search)
born » boon (Expand Search)
hong » long (Expand Search), kong (Expand Search)
hongyu » longyu (Expand Search), kongyu (Expand Search)
honey » money (Expand Search)
bdone » done (Expand Search), bone (Expand Search), bhone (Expand Search)
born » boon (Expand Search)
-
201
The bHLH transcription factor OsPRI1 activates the Setaria viridis PEPC1 promoter in rice
Published 2024“…</li> <li>Yeast one-hybrid screening was used to show that OsPRI1, a rice bHLH transcription factor involved in iron homeostasis, binds to the <i>Setaria viridis PEPC1</i> promoter. …”
Journal article -
202
Reading and translating with scripture - a study of textual growth in the Enochic theophany in the Book of the Watchers 1:1-9
Published 2022Subjects:Thesis -
203
Light trapping in hybrid nanopyramid and nanohole structure silicon solar cell beyond the Lambertian limit
Published 2014Get full text
Get full text
Journal Article -
204
Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing
Published 2013“…In this study, we investigated the efficacy of siRNA–poly(caprolactone-co-ethylethylene phosphate) nanofibers in controlling fibrous capsule formation through the down-regulation of collagen type I (COL1A1) in vitro and in vivo. By encapsulating complexes of COL1A1 siRNA with a transfection reagent (Transit TKO) or the cell penetrating peptides CADY or MPG within the nanofibers (550–650 nm in diameter), a sustained release of siRNA was obtained for at least 28 days (loading efficiency ∼60–67%). …”
Get full text
Get full text
Journal Article -
205
Identification of a novel mitochondria-localized LKB1 variant required for the regulation of the oxidative stress response
Published 2023“…The tumor suppressor Liver Kinase B1 (LKB1) is a multifunctional serine/threonine protein kinase that regulates cell metabolism, polarity, and growth and is associated with Peutz-Jeghers Syndrome and cancer predisposition. …”
Get full text
Journal Article -
206
“双城” 新加坡与香港 : “一带一路”的策略及其反应 = “Twin Cities” Singapore and Hong Kong : belt road initiative strategies and responses
Published 2020“…This paper will use it as a reference point on “Twin Cities”, namely Singapore and Hong Kong, to review their various considerations and strategies. …”
Get full text
Thesis-Master by Research -
207
-
208
-
209
Dynamics of the blood plasma proteome during hyperacute HIV-1 infection
Published 2024“…Six distinct longitudinal expression profiles are identified, of which four demonstrate a consistent decrease in protein levels following HIV-1 infection. Proteins involved in inflammatory responses, immune regulation, and cell motility are significantly altered during the transition from pre-infection to one month post-infection. …”
Journal article -
210
Loss of caveolin-1 impairs light flicker-induced neurovascular coupling at the optic nerve head
Published 2022“…Cav-1 KO mice exhibited higher IOP and lower pSTR amplitude. …”
Get full text
Journal Article -
211
-
212
-
213
Selective Recovery of Gold from E-Wastewater Using Poly-<i>m</i>-phenylenediamine Nanoparticles and Assembled Membranes
Published 2024“…The Au@PmPD membrane loaded with 4 mg gold exhibited a high catalytic reduction performance with an apparent rate constant of 0.59 min−1 , one of the highest catalytic degradation rate constants of p-nitrophenol reported to date. …”
Get full text
Article -
214
TCR affinity biases Th cell differentiation by regulating CD25, Eef1e1, and Gbp2
Published 2019“…Rather, high-affinity T cells sustained IL-2R expression longer and expressed two novel Th cell differentiation regulators, Eef1e1 and Gbp2, to a higher level than low-affinity T cells. …”
Get full text
Get full text
Get full text
Journal Article -
215
TEOSINTE BRANCHED1/CYCLOIDEA/PROLIFERATING CELL FACTOR4 Interacts with WRINKLED1 to mediate seed oil biosynthesis
Published 2020“…Transcriptomic analysis in transgenic Arabidopsis plants with enhanced TCP4 activity engineered by expressing rTCP4 (i.e. miR319-resistant TCP4) revealed that AtWRI1 target genes were significantly repressed. …”
Get full text
Journal Article -
216
Efficient and stable all-inorganic perovskite solar cells based on nonstoichiometric CsₓPbI₂Brₓ (x > 1) alloys
Published 2021“…Here we report a systematic study of all-inorganic perovskite-inspired systems based on CsₓPbI₂Brₓ alloys with x ranging from 0.95 to 4. The identified optimal non-stoichiometric composition Cs₁.₂PbI₂Br₁.₂ delivered the best optoelectronic, structural and photovoltaic characteristics in combination with the improved stability. …”
Get full text
Journal Article -
217
Analyzing conformational changes in single FRET-labeled A1 parts of archaeal A1AO-ATP synthase
Published 2018Subjects: Get full text
Get full text
Journal Article -
218
-
219
HSV-1 amplicon system for human artificial chromosome formation in human ES/iPS cells and pluripotency induction
Published 2012“…To develop HAC in hiPS cells, the first part of the study was aimed at generating hiPS cells utilising the Herpes Simplex Virus (HSV)-1 amplicon system. With the use of EBNA-1/OriP retention elements incorporated into the HSV-1 amplicon vectors, hiPS cells completely free of vector and transgenes sequences were successfully derived from human embryonic fibroblasts. …”
Thesis -
220
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Published 2024“…In preclinical cancer models, GDF-15 blockade synergistically enhanced the efficacy of anti-PD-1-mediated checkpoint inhibition3. In a first-in-human phase 1–2a study (GDFATHER-1/2a trial, NCT04725474), patients with advanced cancers refractory to anti-PD-1 or anti-PD-L1 therapy (termed generally as anti-PD-1/PD-L1 refractoriness) were treated with the neutralizing anti-GDF-15 antibody visugromab (CTL-002) in combination with the anti-PD-1 antibody nivolumab. …”
Journal article